Ronald Evan Wheeler

US Patent:

6365340, Apr 2, 2002

Filed:

Nov 11, 1999

Appl. No.:

09/438722

Inventors:

Ronald E. Wheeler - Durango CO 81302

International Classification:

C12Q 100

US Classification:

435 4, 435 74, 435 19, 4352877, 4352879, 435970, 436518, 436524, 436810, 436823, 530380

Abstract:

The present invention is directed to a method of detecting prostatitis comprising obtaining an expressed prostatic secretion from a patient; contacting a device having diagnostic test reagents to the expressed prostatic secretion, the diagnostic test reagents reacting with the expressed prostatic secretion to produce a change in the device; reading the change in the device to produce a positive or negative experimental test result, wherein the experimental test result is positive when the experimental test result is pre-determined to correspond with a number above 10 for the number of white blood cell per high powered field and the experimental test result is negative when the experimental test result corresponds with a number of 10 or less for the number of white blood cell per high powered field; and determining presence of prostatitis with the positive experimental test result and the absence of prostatitis with the negative experimental test result. The present invention is also directed to a device for use in the inventive method. The device has two indicators, one for the presence of prostatitis and one for the absence of prostatitis.

US Patent:

61973092, Mar 6, 2001

Filed:

Aug 3, 1999

Appl. No.:

9/368297

Inventors:

Ronald E. Wheeler - Durango CO

International Classification:

A61K 3578
A61K 3332

US Classification:

4241951

Abstract:

A composition providing an all-natural, non-surgical preventative of or improvement to disorders of the prostate gland is described. The invention relates to a composition for the prevention of or improvement of prostatitis, and for relieving symptoms and improving objective signs of prostatitis. The formula of the composition preferably includes the following ingredients each in a therapeutically effective amount: Vitamin C, Vitamin B6, Vitamin E, zinc, glycine, L-alanine, Glutamic acid, Saw palmetto, Pygeum extract, Pumpkin seed, Stinging nettle, Echinacea, garlic, Ginkgo leaves, and selenium.

US Patent:

20170312550, Nov 2, 2017

Filed:

Apr 27, 2016

Appl. No.:

15/139841

Inventors:

Ronald E. Wheeler - Sarasota FL, US

International Classification:

A61N 7/02
A61B 34/10
A61B 90/00
A61B 90/00
A61B 34/10
A61N 7/00
A61B 90/00

Abstract:

A method for HIFU treatment of localized prostate cancer in a patient includes identifying the cancer locations in a patient's prostate; visually segmenting the patient's prostate into areas for analysis and treatment, where the section including the area of most aggressive cancer is determined to be the primary area. The primary area is subjected to a first full HIFU treatment for a period intended to ablate the cancerous tumor. HIFU treatment is then stopped on the primary area and the primary area is allowed to rest while simultaneously subjecting the next contiguous area of the patient's prostate to a first HIFU treatment to ablate any additional areas of suspected cancer in the next contiguous area. HIFU treatment is then stopped in the contiguous area. The primary area is then subjected to a second full HIFU treatment for a period sufficient to ensure the complete ablation of the cancerous tumor. The method further includes repeating alternating full HIFU treatment processes on subsequent contiguous areas of the patient's prostate to ensure the complete ablation of any cancerous tumors in the patient's prostate. The entire process is completed under one treatment of anesthesia.

Address:

1326 Lakewood Dr, Jacksonville, FL 32259

Phone:

(904)2875770

VIN:

JTDBT923871039337

Make:

TOYOTA

Model:

YARIS

Year:

2007